Genetic analysis of pbp2x in clinical Streptococcus pneumoniae isolates in Quebec, Canada

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 6, 2005, Pages 832-839

  Granger, Dominic ^a,b   Boily Larouche, Geneviève ^a   Turgeon, Pierre ^b,c   Weiss, Karl ^b,d   Roger, Michel ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

lactams; Cefotaxime resistance; Penicillin resistance; Penicillin binding proteins; Pneumococci; Serotype

Indexed keywords

AMINO ACID; BETA LACTAM ANTIBIOTIC; CEFUROXIME; GAMMA GLUTAMYLTRANSFERASE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 2X; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANADA; CODON; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PROTEIN MOTIF; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; BETA-LACTAM RESISTANCE; HUMANS; MOLECULAR SEQUENCE DATA; PENICILLIN-BINDING PROTEINS; STREPTOCOCCUS PNEUMONIAE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 21244441053     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki118     Document Type: Article

References (32)

1. Ghuysen JM. Serine β-lactamases and penicillin-binding proteins. Annu Rev Microbiol 1991; 45: 37-67.
2. Coffey TJ, Daniels M, McDougal LK et al. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1995; 39: 1306-13.
3. Hakenbeck R, Ellerbrok H, Briese T et al. Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the β-lactam binding site. Antimicrob Agents Chemother 1986; 30: 553-8.
4. Laible G, Hakenbeck R. Five independent combinations of mutations can result in low-affinity penicillin-binding protein 2x of Streptococcus pneumoniae. J Bacteriol 1991; 173: 6986-90.
5. Grebe T, Hakenbeck R. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of β-lactarn antibiotics. Antimicrob Agents Chemother 1996; 40: 829-34.
6. Krauss J, van der Linden M, Grebe T et al. Penicillin-binding proteins 2x and 2b as primary PBP targets in Streptococcus pneumoniae. Microb Drug Resist 1996; 2: 183-6.
7. Sifaoui F, Kitzis MD, Gutmann L. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral β-lactam antibiotics is associated with alterations of PBP2x. Antimicrob Agents Chemother 1996; 40: 152-6.
8. Pares S, Mouz N, Petillot Y at al. X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme. Nat Struct Biol 1996; 3: 284-9.
9. Asahi Y, Takeuchi Y, Ubukata K. Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates. Antimicrob Agents Chemother 1999; 43: 1252-5.
10. Chesnel L, Pernot L, Lemaire D et al. The structural modifications induced by the M339F substitution in PBP2x from Streptococcus pneumoniae further decreases the susceptibility to β-lactams of resistant strains. J Biol Chem 2003; 278: 44448-56.
11. Mouz N, Di Guilmi AM, Gordon E et al. Mutations in the active site of penicillin-binding protein PBP2x from Streptococcus pneumoniae. Role in the specificity for β-lactam antibiotics. J Biol Chem 1999; 274: 19175-80.
12. Nagai K, Davies TA, Jacobs MR et al. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1 a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin -susceptible, -intermediate, and -resistant pneumococci. Antimicrob Agents Chemother 2002; 46: 1273-80.
13. Nichol KA, Zhanel GG, Hoban DJ. Penicillin-binding protein 1A, 213, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 2002; 46: 3261-4.
14. Smith AM, Klugman KP, Coffey TJ at al. Genetic diversity of penicillin-bindingprotein 2B and 2X genes from Streptococcus pneumoniae in South Africa. Antimicrob Agents Chemother 1993; 37: 1938-44.
15. Hakenbeck R, Konig A, Kern I et al. Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level β-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J Bacteriol 1998; 180: 1831-40.
16. Munoz R, Coffey TJ, Daniels M et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-6.
17. Overweg K, Bogaert D, Sluijter M et al. Molecular characteristics of penicillin-binding protein genes of penicillin-nonsusceptible Streptococcus pneumoniae isolated in the Netherlands. Microb Drug Resist 2001; 7: 323-4.
18. Sanbongi Y, Ida T, Ishikawa M et al. Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan. Antimicrob Agents Chemother 2004; 48: 2244-50.
19. Pernot L, Chesnel L, Le Gouellec A et al. A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to β-lactam antibiotics. J Biol Chem 2004; 279: 16463-70.
20. duPlessis M, Bingen E, Klugman KP. Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin. Antimicrob Agents Chemother 2002; 46: 2349-57.
21. Low DE, de Azavedo J, Weiss K et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob Agents Chernother 2002; 46: 1295-301.
22. Zhanel GG, Karlowsky JA, Palatnick L et al. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group. Antimicrob Agents Chemother 1999; 43: 2504-9.
23. Zhanel GG, Palatnick L, Nichol KA et al. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003; 47: 1867-74.
24. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A6. NCCLS, Wayne, PA, USA, 2000.
25. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA, 2002.
26. Baek JY, Ko KS, Oh WS et al. Unique variations of pbp2b sequences in penicillin-nonsusceptible Streptococcus pneumoniae isolates from Korea. J Clin Microbiol 2004; 42: 1746-50.
27. Dowson CG, Hutchison A, Brannigan JA et al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1989; 86: 8842-6.
28. Laible G, Spratt BG, Hakenbeck R. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1991; 5: 1993-2002.
29. Mouz N, Gordon E, Di Guilmi AM et al. Identification of a structural determinant for resistance to β-lactam antibiotics in gram-positive bacteria. Proc Natl Acad Sci USA 1998; 95: 13403-6.
30. Ferroni A, Berche P. Alterations to penicillin-binding proteins 1A, 2B and 2X amongst penicillin-resistant clinical isolates of Streptococcus pneumoniae serotype 23F from the nasopharyngeal flora of children. J Med Microbiol 2001; 50: 828-32.
31. Smith AM, Botha RF, Koornhof HJ et al. Emergence of a pneumococcal clone with cephalosporin resistance and penicillin susceptibility. Antimicrob Agents Chemother 2001; 45: 2648-50.
32. Hakenbeck R, Kaminski K, Konig A et al. Penicillin-binding proteins in β-lactam-resistant Streptococcus pneumoniae. Microb Drug Resist 1999; 5: 91-9.